Ads
related to: pharmacogenomic testing companieslifelinescreening.com has been visited by 10K+ users in the past month
- Find a Location Near You
Book Your Appointment Today.
No Insurance Required.
- Get a Body Scan for $159
4 Tests All For 1 Price of $159
Find A Location Near You
- 50% Off Screening Packs
Get 4 Tests & Save -
Special Package Pricing - Book Now
- Testimonials & Reviews
Real Clients, Real Peace of Mind.
Hear Firsthand Experiences.
- Find a Location Near You
Search results
Results From The WOW.Com Content Network
In the summer of 2022, Brown got a letter in the mail from her health insurance company offering a free pharmacogenomic test created by the Minneapolis-based company OneOme that would help her ...
Tempus does genome sequencing and precision medicine, including diagnostics, primarily for cancer patients, as well as for cardiology patients, radiology, and pharmacogenomic testing for patients with depression. [8] Tempus has a global presence for its products and services in 34 countries. [9]
Likewise, companies like deCODE genetics, MD Labs Pharmacogenetics, Navigenics and 23andMe offer genome scans. The companies use the same genotyping chips that are used in GWAS studies and provide customers with a write-up of individual risk for various traits and diseases and testing for 500,000 known SNPs. Costs range from $995 to $2500 and ...
Myriad Genetics, Inc. is an American genetic testing and precision medicine company based in Salt Lake City, Utah, United States.Myriad employs a number of proprietary technologies that permit doctors and patients to understand the genetic basis of human disease and the role that genes play in the onset, progression and treatment of disease.
In 2018, the company launched its flagship product, myGenome, with the stated goal of providing consumers with information about their inherited genetic risk including cancer, cardiovascular and carrier status, reaction to certain medications (pharmacogenomics) and more, all based on whole-genome sequencing results. The company further reduced ...
The company started in the Technology Development Center, a biotech incubator supported by the state of Maryland and Montgomery County, MD. In 2006, BioReference Laboratories acquired GeneDx. [8] Since then, GeneDx has operated as a subsidiary of this parent company under the leadership of Bale (retired in 2016) and Compton (retired in 2013). [9]